23-10-2024 | Frank Quinn re-joins Align Technology as Executive Vice President and Managing Director of the Americas | region NDAQ: ALGN

Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company offering the Invisalign® System of clear aligners, iTero™ intraoral scanners and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Frank Quinn, formerly Align vice president and general manager of the United States, will rejoin the company as executive vice president and general manager of the Americas region, reporting to Joe Hogan, president and CEO of Align. As part of the global organizational restructuring plan that the company separately announced today, the position of Raj Pudipeddi’ Executive Vice President and Managing Director of the Americas Region and Chief Marketing Officer has been eliminated and he will leave Align in the fourth quarter of 2024.

Commenting on today’s announcement, Joe Hogan, president and CEO of Align Technology, said: “I am pleased to welcome Frank Quinn back to Align as EVP and Managing Director, Americas. Frank’s experience, deep knowledge of the orthodontic and dental industries and insights into what digital means for our physician customers are critical and he is excited to rejoin the company. He is an established leader with a solid customer focus and proven track record, and I am confident Frank will help facilitate the growth and adoption of our products and drive focused execution across the Americas region. We thank Raj for his contributions to Align over the past five years in leading our marketing and product innovation/management and overseeing the APAC and Americas regions, and we wish Raj the best.”

Frank Quinn, Executive Vice President and Managing Director, Americas

Frank Quinn is Executive Vice President and Managing Director of the Americas region. He is responsible for the market development and operational execution of all Align Technology products and services in the North and South America region. Mr. Quinn rejoined Align in October 2024 after two years at LightForce Orthodontics, where he served as Chief Revenue Officer. Prior to joining LightForce, Mr. Quinn spent nearly nine years at Align, serving in a variety of roles, including Vice President and General Manager, where he was responsible for driving continued growth and profitability for the United States. During his time at Align, Mr. Quinn’s other roles included Senior Sales Director of Special Markets and iTero, Vice President of Special Markets, Business Development and Education. Mr. Quinn has a wealth of experience driving growth, strategy and revenue in the orthodontics industry. A successful executive leader in the medical and technology industries, he combines strong sales leadership experience with expertise in business development, innovation, professional education, commercial operations and culture building. Mr. Quinn also served as a board member of the American Association of Orthodontics Foundation (AAOF) and the American Academy of Clear Aligners (AACA). He holds a bachelor’s degree in business administration and marketing from Montclair State University.

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign® System, the world’s most advanced clear aligner system, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiency for more than 271,000 physician customers and are critical to accessing Align&CloseCurlyQuote’s 600 million consumer markets worldwide. Over the past 27 years, Align has helped physicians treat approximately 18.9 million patients with the Invisalign system and is driving the evolution of digital dentistry through the Align™ Digital Platform, our integrated suite of unique, patented technologies and services delivered as a seamless end device. -to-end solution for patients and consumers, orthodontists and general practitioners, and laboratory/partners. Visit www.aligntech.com for more information.

For more information about the Invisalign system or to find an Invisalign doctor near you, visit www.invisalign.com. For more information about the iTero digital scanning system, visit www.itero.com. For additional information about Exocad’s dental CAD/CAM offerings and a list of Exocad reseller partners, visit www.exocad.com.

Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.

Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding beliefs and expectations regarding our ability to successfully control our business and operations and pursue our strategic growth engines, our expectations for market opportunities, our expectations for the growth and adoption of our products and commercial executions in the Americas region, and other matters discussed in this press release that are not purely historical data. Forward-looking statements in this press release regarding expectations about future events or results are based on information available to Align as of the date hereof. Readers are cautioned that these forward-looking statements reflect our best judgments based on currently known facts and circumstances and are subject to risks, uncertainties and assumptions that are difficult to predict. As a result, actual results may differ materially and adversely from those expressed in any forward-looking statement.

Factors that could cause such a difference include, but are not limited to:

• macroeconomic conditions, including inflation, fluctuations in exchange rates, high interest rates, market volatility, weakness in general economic conditions and recessions and the impact of efforts by central banks and federal, state and local governments to combat inflation and recession;

• the purchasing behavior of customers and consumers and changes in consumer spending patterns due to, among other things, prevailing macroeconomic conditions, employment levels, salaries and wages, debt obligations, discretionary income, inflationary pressures, declining consumer confidence and the military conflict in Ukraine and in the Middle East;

• variations in our geographic, channel and product mix, product acceptance and sales prices regionally and globally, including shifts in product mix toward lower priced products or toward products with a higher percentage of deferred revenue;

• competition from existing and new competitors;

• declines in, or slowdown in growth of, sales of our clear aligners and intraoral scanners domestically and/or internationally and the impact either would have on the adoption of Invisalign products;

• the economic and geopolitical consequences of the military conflict in the Middle East and Ukraine, including trade disruptions, tariffs, sanctions or boycotts, retaliatory sanctions, nationalism, supply chain disruptions and other consequences, any of which could adversely impact our operations and assets ;

• the possibility that the development and release of new products or improvements to existing products may not proceed according to the expected timeline or may themselves contain bugs, errors or defects in software or hardware that require correction and that the market for the sale of these new or hardware improved products may not develop as expected;

• the timing, availability and costs of raw materials, components, products and other transportation and supply chain constraints and disruptions;

• unexpected or rapid changes in the growth or decline of our domestic and/or international markets;

• rapidly evolving and disruptive developments that fundamentally change the dental industry or the way new and existing customers market and deliver products and services to consumers;

• the willingness and ability of our customers to maintain and/or increase product use in sufficient quantities;

• the risks associated with our ability to maintain or increase profitability or revenue growth in future periods (or minimize declines) while controlling costs;

• expanding our activities and products;

• the impact of excessive or limited capacity at our manufacturing and treatment facilities and the strain on our internal systems and personnel;

• compromising our systems or networks, including any customer and/or patient data contained therein, for any reason;

• the timing of case submissions from our physician customers within a quarter, as well as increased production costs per case; And

• the loss of key personnel, labor shortages or work stoppages for us or our suppliers.

The foregoing and other risks are detailed from time to time in our periodic reports filed with the Securities and Exchange Commission (“SEC”), including, but not limited to, our Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC on February 28, 2024, and our latest Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, which was filed with the SEC on August 2, 2024. Align undertakes no obligation to revise or publicly update any forward-looking statements for any reason.

View the source version on businesswire.com: https://www.businesswire.com/news/home/20241023839496/en/